Hormonal
Roux-en-Y gastric bypass (RYGB) induces type 2 diabetes remission primarily by restoring beta-cell glucose sensitivity, whereas improvements in insulin sensitivity are proportional to weight loss and do not independently predict remission.
For patients undergoing gastric bypass, weight loss alone does not guarantee diabetes remission. The key biological factor is the recovery of the pancreas's ability to sense and respond to glucose (beta-cell sensitivity). Patients with severe initial beta-cell dysfunction may not achieve remission even with significant weight loss. Monitoring metabolic markers beyond weight is crucial.
In morbid obesity, Roux-en-Y gastric bypass causes rapid and profound metabolic adaptations; insulin sensitivity improves in proportion to the weight loss, and beta-cell glucose sensitivity increases independently of weight loss. Over a period of 1 yr after surgery, diabetes remission depends on the starting degree of beta-cell dysfunction.
Why this rating
Prospective clinical study with rigorous metabolic testing (OGTT modeling) and clear statistical predictors, though limited to a single center and specific surgical technique.
Source
The Role of β-Cell Function and Insulin Sensitivity in the Remission of Type 2 Diabetes after Gastric Bypass Surgery
Monica Nannipieri et al. · The Journal of Clinical Endocrinology & Metabolism · 2011
DOI 10.1210/jc.2011-0446
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →